Cenduit to expand its offices in US, Switzerland
The expansion will add more room space to the company’s headquarters and triples the size of its office in Basel. Cenduit CEO Jogin Desai said the firm’s decision
Bristol Myers Squibb (BMS) is set to merge its separate research and development (R&D) departments into a single entity, effective from 1 January 2027.
Under the partnership, Crystal Pharmatech combines its expertise with Particle Sciences advanced drug delivery solutions compounds to offer clients an optimal solution for developing low solubility pharmaceutical compounds.